Press Release
Thursday, June 30, 2016
Strides Shasun Limited Star II, Bannerghatta Road, Bangalore - 560076.
Strides Shasun announces successful completion of US FDA inspection at its Oral Dosage Facility in Bangalore Zero 483's Status Bangalore, June 30, 2016 Strides Shasun Limited today announced successful completion of USFDA inspection at its flagship Oral Dosage Facility in Bangalore with "Zero 483s".The Audit was carried out related to a product filed from the new semi solids block from where the Company has made a series of filings.
With the recently closed Establishment Inspection Report (EIR) announced on June 7, 2016, the entire facility is now US FDA compliant.
The Oral Dosage facility (KRS Gardens facility) in Bangalore manufactures oral dosage forms including tablets, capsules (both hard gelatine and soft gelatine), ointments and liquids. The manufacturing plant supports important current and future submissions for the US Market
About Strides Shasun LimitedStrides Shasun, listed on the BSE Limited (532531) and National Stock Exchange of India Limited (STAR), is a vertically integrated global pharmaceutical Company headquartered in Bangalore. The Company has four business verticals, viz., Regulated Markets, Emerging Markets, Institutional Business and Pharmaceutical Services & Active Ingredients.
The Company has global manufacturing foot print with 14 manufacturing facilities spread across three continents including 6 US FDA approved facilities and 8 facilities for the emerging markets. The Company has three dedicated R&D facilities in India with global filing capabilities and a strong commercial footprint across 85 countries Additional information is available at the Company's website at www.stridesarco.com
For further information, please contact:Strides Shasun
Badree Komandur, Group CFO
+91 80 6784 0747
Vikesh Kumar +91 80 6784 0827
Kannan. N: +91 98450 54745
Sandeep Baid: +91 80 6784 0791
PR Consultancy
Fortuna PRK Srinivas Reddy: +91 9000527213 srinivas@fortunapr.com
K Priya: +91 9535425418
priya@fortunapr.com
Strides Arcolab Limited published this content on 30 June 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 01 July 2016 04:45:09 UTC.
Original documenthttp://www.stridesarco.com/pdf/pressrelease/2016/strides_shasun_press_release_30_jun_16.PDF
Public permalinkhttp://www.publicnow.com/view/E2AB680A15271D98BC4935B27117B5B8F322698A